「血圧140切ってるからセーフ! ふう
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2021 – Nov 2025Where it's discussed
-
X / Twitter172 posts
-
News28 articles
-
YouTube6 videos
-
Facebook5 posts
-
Blogs3 articles
-
Reddit2 posts
AI synopsis
What people are saying
Numerous discussions highlight the key findings of the trial, particularly the effectiveness of targeting systolic blood pressure below 120 mm Hg to reduce major cardiovascular events and all-cause mortality. Phrases like 'significantly lowered the risk' and 'critical implications for treatment' illustrate the urgency and relevance of the research, while comments addressing potential risks emphasize the need for cautious adoption of these findings.
Most discussions indicate a positive reception towards the findings of the trial, with many acknowledging its significance.
The majority of participants express high levels of curiosity about the trial's outcomes and implications for cardiovascular health.
Many comments reference specific details about the trial, including the comparison between blood pressure targets and related health outcomes.
Poster perceives the study's conclusions as significantly impacting clinical practices in blood pressure management.
Abstract in brief
- The trial involved 9,361 participants at risk for cardiovascular disease who were assigned either intensive treatment aiming for a systolic blood pressure of 120 mm Hg or standard treatment set at 140 mm Hg.
- The results showed that the intensive treatment group had a lower rate of major cardiovascular events and all-cause mortality, with 177 events per year compared to 240 in the standard group, and a lower all-cause mortality rate of 106 versus 141.
- However, there were more serious adverse events, such as hypotension and kidney issues, in the intensive treatment group, highlighting the need for cautious management.
Top posts
Most liked on X and BlueskyThe SPRINT trial also showed that, despite more side effects, intensive blood pressure treatment to reach the lower blood pressure goal is safe – even in older people. Intensive treatment prevented more heart attacks, strokes and deaths. https://t.co/rNliSs9Pun 6/
⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP control lessened HF HR 1.63, 95 CI 1.02-2.57 Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/O0x5YqX4EI
You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/667yqxFEMb
Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA @ISHBP @AnastasiaSMihai @HTNCanada @JJheart_doc @AShchendrygina @DrMarthaGulati @SABOURETCardio @pabeda1 @MiguelCamafort https://t.co/ooFH71EhrT
Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/Xfjw6BDudj
All mentions
Effective Exercise Strategies for Lowering Blood Pressure
Exercise has long been a go-to solution for lowering blood pressure. A new study reveals an incredibly simple yet powerful exercise that could significantly benefit individuals at risk for cardiovascular disease…
Effective Exercise for Lowering Blood Pressure
This video discusses an effective exercise to lower blood pressure. High blood pressure increases the risk of heart attacks and strokes. Recent research highlights the importance of physical activity as a key ally in…
Blood Pressure Targets Just Changed
Impact of Exercise on Arterial Health and Atherosclerosis
Plaque buildup in your arteries is a major contributor to heart disease. This video explores findings from a groundbreaking study linking exercise to coronary health, revealing how varying exercise intensities may…
Reducing Dementia Risk Through Intensive Blood Pressure Management
This study investigates the long-term effects of intensive blood pressure control (SBP of 120 mm Hg) versus standard (SBP of 140 mm Hg) on cognitive impairment and dementia. Results show that intensive management may…
Hipertensão e Exercício Físico - Luiz Scaf Traininer
Results of a study (https://t.co/klNPvJHXHV) indicate patients at risk for cardiovascular events that targeted a systolic blood pressure (BP) of less than 120 mm Hg (intensive treatment) resulted in lower rates cardiovascular events. https://t.co/VTsfAsLw4s https://t.co/oU9dellvwe
Results of a study (https://t.co/MAri8S2qWE) indicate patients at risk for cardiovascular events that targeted a systolic blood pressure (BP) of less than 120 mm Hg (intensive treatment) resulted in lower rates cardiovascular events. https://t.co/7PhuR1pIO5 https://t.co/1hGl79lHTV
RT @BradStanfieldMD: Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/Xfjw6BDudj
Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/x4Z5P5gWzo via @YouTube
Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/HUKOM0PC9n via @YouTube @ifdadwashere @IfDadWasHere1
RT @BradStanfieldMD: Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/Xfjw6BDudj
Scientists Just Found an EASY Way to Cut Dementia Risk By 15% https://t.co/Xfjw6BDudj
This Exercise Clears Plaque in Your Arteries! New Trial https://t.co/HNR4AML9Ep via @YouTube
O MELHOR EXERCÍCIO PARA BAIXAR A PRESSÃO ARTERIAL https://t.co/jqFBuPhDGM via @YouTube
RT @MichaelHen26343: This Exercise Clears Plaque in Your Arteries! New Trial https://t.co/3MvlMTguDP via @YouTube https://t.co/s1RbysHPlM
This Exercise Clears Plaque in Your Arteries! New Trial https://t.co/3MvlMTguDP via @YouTube https://t.co/s1RbysHPlM
Clearing plaque from your arteries https://t.co/eu79MGYPKB
This Exercise Clears Plaque in Your Arteries! New Trial https://t.co/0bo8MIYvvF via @YouTube
https://t.co/JXrVzVWvjV
https://t.co/KcgvMHES3o
RT @DoctorTro: https://t.co/gWGP8HmkN9
RT @DoctorTro: https://t.co/gWGP8HmkN9
https://t.co/gWGP8HmkN9
@PierreKory @MidwesternDoc https://t.co/gWGP8HmkN9
@Brain24Gd9144 例えば 高齢者高血圧患者のSPRINT試験では 血圧を ・140mmHgまで下げた患者(標準)と ・120mmHgまで下げた患者(厳格) の心筋梗塞や脳卒中、心不全発症を検討。 降圧剤で120mmHgまで下げても初期の心筋梗塞や脳卒中の増加は認められず更に25%減少しています!! https://t.co/q9NpMKVfCi https://t.co/ib3bYiMcU2
@Brain24Gd9144 例えば 高齢者高血圧患者の 血圧を ・140mmHgまで下げた患者(標準)と ・120mmHgまで下げた患者(厳格) の心筋梗塞や脳卒中、心不全発症を検討したSPRINT試験では 降圧剤で120mmHgまで下げても初期の心筋梗塞や脳卒中の増加は認められず更に25%減少しています!! https://t.co/q9NpMKVfCi https://t.co/wkssl7gPVU
RT @cardiomet_CE: 14) Do note that #SPRINT excluded patients with #T2D and #proteinuria ≥1 g/day. Intensive treatment ⬇️ #CV outcomes but h…
14) Do note that #SPRINT excluded patients with #T2D and #proteinuria ≥1 g/day. Intensive treatment ⬇️ #CV outcomes but had little effect on #kidney outcomes.
@DrAdamBat @nntaleb There is also this https://t.co/Nf78u21bHe and... this https://t.co/571LBxxdJQ
RT @ckd_ce: 14) Do note that #SPRINT excluded patients with #T2D and #proteinuria ≥1 g/day. Intensive treatment ⬇️ #CV outcomes but had lit…
14) Do note that #SPRINT excluded patients with #T2D and #proteinuria ≥1 g/day. Intensive treatment ⬇️ #CV outcomes but had little effect on #kidney outcomes.
@eemoin SPRINT away from those answer choices. https://t.co/1sEECHx1Uj
ハイリスク患者に対する厳格な降圧治療(SBP<120)は、通常の降圧治療(SBP<140)よりも心筋梗塞や脳卒中を減らす(1.77%/年 vs 2.40%/年:HR=0.73 [95%CI: 0.63-0.86])が、低血圧や失神・急性腎障害の有害事象も多い。 N Engl J Med.384(20):1921-30,(2021) PMID: 34010531 https://t.co/5Z3bwfREbl
RT @uni_pharmacist: SPRINTのfinal reportでも、1年通常コントロールに戻しただけで心不全は2.3倍! Final Report of a Trial of Intensive versus Standard Blood-Pressure Co…
SPRINTのfinal reportでも、1年通常コントロールに戻しただけで心不全は2.3倍! Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/lCOPdqImd0
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @WakeBDS: Among patients at increased cardiovascular risk, targeting a SBP of less than 120 mm Hg (vs. less than 140 mm HG) resulted in…
Among patients at increased cardiovascular risk, targeting a SBP of less than 120 mm Hg (vs. less than 140 mm HG) resulted in lower rates of major adverse cardiovascular events. #PHSTop10 #epitwitter Congrats to @wambrosius and @dmrebouss from BDS! https://t.co/1nPDD6OcB7
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/sUPtl7988l
#062 Final Report of a Trial of Intensive versus Standard Blood-Pressure Control N Engl J Med 2021;384:1921-30. SPRINT最終結果 140未満よりも120未満の方が、やはりいいのか
New study shows F/U Sprint confirms benefits of sBP <120 (MI, HF, and CV death but not stroke); Was increase in sBP after trial due to adjusting meds causing syncope/hypotension? @NEJM https://t.co/amXljG4ElJ #target_BP #systolic #bloodpressure
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control - PubMed https://t.co/BYhPqO9Hov
RT @AkhmetzhanG: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/0zbfp3BxXC @IJCHypertensi…
RT @AkhmetzhanG: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/0zbfp3BxXC @IJCHypertensi…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/0zbfp3BxXC @IJCHypertension @ESHypertension @ISHBP @MiguelCamafort @AnastasiaSMihai #cardiotwitter #hypertension
3-year follow-up from the SPRINT trial shows that targeting a SBP<120mmHg led to a lower risk of major adverse #CV events and all-cause mortality compared with SBP<140mmHg but higher rates of some adverse events. @NEJM https://t.co/caInp7nlCE
Según un artículo reciente publicado en el NEJM (Final Report of a Trial of Intensive versus Standard Blood-Pressure Control) metas de presión sistólica <120 mmHg en comparación con la meta tradicional de <140 mmHg se asocia con menos eventos cardiovasculares y menor mortalidad https://t.co/3UTe7lFEpM
RT @pecoitsfilho: @hswapnil @HecmagsMD @CharlieTomson @goKDIGO @GregKnoll99 @cellotonelli @taraichang https://t.co/MgZpyKcrPW, when when th…
@hswapnil @HecmagsMD @CharlieTomson @goKDIGO @GregKnoll99 @cellotonelli @taraichang https://t.co/MgZpyKcrPW, when when they do, they do it again and again #NephJC
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/c23MvtTMsv
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/FOpYFWiXop
Let's put that in context of the final results from #SPRINT too! https://t.co/aoxep2PdMp
Should we be more aggressive with #BloodPressure control? SPRINT trial: Controlling SBP<120 vs <140 reduced annual risk of MI/ACS/stroke/acute HF/death by 27% and all-cause mortality by 25%. Although, some adverse events more frequent. It seems yes. https://t.co/unabMb08nH
RT @ASPNeph: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/52YjDaVxxz @NEJM #BP #SPRINT
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/52YjDaVxxz @NEJM #BP #SPRINT
Buried in the ongoing news cycle this May is the insightful and essential SPRINT trial. Getting systolic #bloodpressure (the top number) from the usual target of 140 down to 120 significantly lowered the risk of heart attacks and stroke. Know your numbers. https://t.co/sbUDu5N9vu
Aggressive blood pressure management (carried out with the help of #DigitalTherapeutics) is associated with better cardiovascular outcomes than taking a more traditional approach, according to new findings published in @NEJM. https://t.co/syxe0AYgab | #HeartFailure
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
RT @MRrenaldoc: Lower is still better! https://t.co/0ScBRyXeHB
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/1fOHOU1PvB Important study, but the conclusions are ambiguous.
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
https://t.co/Bg7QW4WHdy
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/V6a1yHiuH4
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/1Jo6HxusUu
RT @SeguraCardio:
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/ZDQOW49s9z
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
血圧は低めにコントロール!! Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/Lg50BhvOu5
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
https://t.co/mEocICPDwi
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
What an amazing run...I sense humor in "final" given all the research still likely to come from this data resource. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/AxRtbvY1BD
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @J_Circ_Assoc: 「血圧140切ってるからセーフ! ふう
「血圧140切ってるからセーフ! ふう
SPRINT trial reports that intensive treatment to lower blood pressure results in fewer major #cardiovascular events and decreased all-cause mortality vs. standard treatment | @NEJM https://t.co/UlyAjds0fA
الأشخاص الذين لديهم خطورة أكبر لأمراض القلب، فإن ضبط #ضغط_الدم بما دون ١٢٠، نتج عنه نسبة مستقبلية أقل لمضاعفات ووفيات القلب، مقارنة بالأشخاص الذين تم ضبط ضغطهم بما دون ١٤٠ بالتأكيد الأعراض الجانبية للأدوية كانت أكثر لدى الأشخاص الذين تم ضبط الضغط دون ١٢٠ https://t.co/TptUU7rbpI
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/wxMvo52dP8
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
RT @HanCardiomd: Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA…
Final Report of a SPRINT Trial of Intensive versus Standard Blood-Pressure Control https://t.co/owpaLDfaPX @NEJM @HyperAHA @ISHBP @AnastasiaSMihai @HTNCanada @JJheart_doc @AShchendrygina @DrMarthaGulati @SABOURETCardio @pabeda1 @MiguelCamafort https://t.co/ooFH71EhrT
入院患者の血圧指示でsBP<120っていう指示を何気なく出してたけど、心血管リスクがある患者には意外と意味のある指示なのかも https://t.co/dqMXGQ4vGy
RT @drjkahn: Important and Hard to Achieve! Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.c…
Important and Hard to Achieve! Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/BfuYuToIXD #kahnchronicle
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. https://t.co/T3Cnck94Yi
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control: N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281.ABSTRACTBACKGROUND: In a pre... https://t.co/u4LV6NDB6x
RT @ASPNeph: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. The #SPRINT Research Group #HTN @NEJM https://t.…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/uc0NDdn7Ob
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/OFbJyrCrwL
RT @ASPNeph: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. The #SPRINT Research Group #HTN @NEJM https://t.…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. The #SPRINT Research Group #HTN @NEJM https://t.co/oK1Ej10mKp https://t.co/oTUmLfeqoG
RT @DrTomFrieden: The SPRINT trial also showed that, despite more side effects, intensive blood pressure treatment to reach the lower blood…
RT @DrTomFrieden: The SPRINT trial also showed that, despite more side effects, intensive blood pressure treatment to reach the lower blood…
RT @DrTomFrieden: The SPRINT trial also showed that, despite more side effects, intensive blood pressure treatment to reach the lower blood…
The SPRINT trial also showed that, despite more side effects, intensive blood pressure treatment to reach the lower blood pressure goal is safe – even in older people. Intensive treatment prevented more heart attacks, strokes and deaths. https://t.co/rNliSs9Pun 6/
Nutshell #270: Systolic blood pressure below 120 mm Hg was associated with a 42% lower likelihood of cardiovascular mortality compared to between 120 and 140 mm Hg in patients with hypertension. @NEJM https://t.co/7MVJFkssoG
Articule of the week and it’s not about technology in #DM
Trial of Intensive versus Standard Blood-Pressure Control. In non diabetic patients with vascular risk factors, intensive less than 120mmhg had lower adverse events than less than 140mmmhg. For primary prevention! https://t.co/DoADyuo0rS
Trend new: Sprint Research Group, ..., Ambrosius WT (N Engl J Med) __Final Report of a Trial of Intensive versus Standard Blood-Pressure Control__ https://t.co/VmLcEBnpX6
RT @gcfmd: ⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP c…
RT @gcfmd: ⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP c…
RT @gcfmd: ⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP c…
RT @FernandoCiveir1: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/maPUU4Ra2z
SPRINT Trial final report: targeting a systolic BP < 120 mmHg in patients at increased CV risk is associated with improved CV and mortality outcomes but increases the risk of serious adverse events – via @NEJM https://t.co/PSLqGImIju Commentary: https://t.co/Aa1CUUasn5
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control - https://t.co/jpgRHLeF9v
RT @gcfmd: ⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP c…
RT @gcfmd: ⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP c…
⬇️ HF risk with intensive SBP strategy Yet once trial ends, rapid rebound in HF risk in the post-intervention period when SBP control lessened HF HR 1.63, 95 CI 1.02-2.57 Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/O0x5YqX4EI
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control @nejm https://t.co/omGNTq6XXf
RT @hillz758: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/KEKiXl66xa
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/KEKiXl66xa
(Final Report of a Trial of Intensive versus Standard Blood-Pressure Control) https://t.co/uHknYe2xNr
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/QYCp1TS23Z
RT @RealTNagasawa: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/1a2QZPY6IE
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/V7U8oOSbga
RT @AshuPJadhav: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/jM8bT3KBOM “Targeting an…
Lower major CV events and lower all-cause mortality in the intensive group (SBP < 120), at expenses of more electrolyte abnormalities and AKI or failure in the total group. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/PCcxyqMh75
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/1a2QZPY6IE
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/maPUU4Ra2z
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/zOCiyCefLp https://t.co/Rxyjifl9Rd
Entre los pacientes que tenían un mayor riesgo cardiovascular, apuntar a una presión arterial sistólica de menos de 120 mm Hg resultó en tasas más bajas de eventos CV. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/TY16ykuzke
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/jM8bT3KBOM “Targeting an SBP of <120 mm Hg resulted in lower rates of major adverse cardiovascular events and lower all-cause mortality than targeting an SBP <140 mm Hg,”
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
New article: Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/uZ9UQW92w8 #alzheimers #neurology https://t.co/UG8SxsdWTP
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control https://t.co/4V2tQDIh2C
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
降圧療法のランダム試験。厳格に下げれば心血管イベントが減るが、低血圧などの副作用も多いことがわかった!(そりゃそうだ…) Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/rftZr0F3bA
RT @ethanjweiss: You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standa…
You might think you had heard everything about SPRINT. You'd be wrong. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control | NEJM https://t.co/667yqxFEMb